Home > Healthcare > Pharmaceuticals > Vaccines > Cholera Vaccines Market

Cholera Vaccines Market Share

Report ID: GMI10163
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Cholera Vaccines Market Share

The cholera vaccine market is fiercely competitive with numerous pharmaceutical and biotech companies vying for dominance. These companies are at the forefront of developing cutting-edge vaccine formulations, boosting production capabilities, and extending their global distribution networks. They strategically collaborate with research institutions and international bodies to strengthen research and development initiatives and expedite regulatory approvals. Additionally, significant investments in advanced vaccine technologies underscore their commitment to meeting the increasing demand for efficient cholera prevention measures in high-risk areas globally.

Cholera Vaccines Market Companies

The company profile section include both companies that have commercial drug available in market as well as those that are onto clinical phase development. Few of the prominent players operating in the cholera vaccines industry include:

Bavarian Nordic A/S
Bharat Biotech
Biological E
EuBiologics Co. Ltd.
Hilleman Laboratories
Incepta Pharmaceuticals Ltd.
Shantha Biotechnics (Sanofi)
Vabiotech
Valneva Sweden AB

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cholera vaccines market size was valued at USD 89.4 million in 2023 and is estimated to grow at 8.4% CAGR from 2024 to 2032, due to the growing global burden of cholera outbreak.

The euvichol/euvichol-plus market size was USD 40.4 million in 2023 and will grow at 8.2% CAGR during 2024-2032, due to their effectiveness, ease of administration, and affordability.

Canada cholera vaccines market accounted for USD 19.3 million in 2023 and is anticipated to showcase considerable growth through 2032, attributed to a comprehensive healthcare system, proactive public health policies, and high vaccination coverage.

Bavarian Nordic A/S, Bharat Biotech, Biological E, EuBiologics Co. Ltd, Hilleman Laboratories, Incepta Pharmaceuticals Ltd., Shantha Biotechnics (Sanofi), Vabiotech, and Valneva Sweden AB among others.